Malady Kyle sold 1,100 Verizon Communications shares at $49.98 each on September 8, leaving the executive with 106,566 shares. The transaction represented about 1.0% of Kyle’s prior holding, giving investors a specific measure of the sale against his ownership position while identifying it as an open-market transaction.
Key Highlights
- The transaction carried code S, classifying it as an open-market sale.
- The sale represented about 1.0% of Malady Kyle’s prior share holding.
- Malady Kyle sold 1,100 shares of Verizon Communications in the transaction.
VERIZON COMMUNICATIONS INC (NYSE: VZ) saw Malady Kyle sell 1,100 shares at $49.98 each on 8 September 2026. Kyle held 106,566 shares after the transaction. Kyle is Verizon Communications’ EVP and Group CEO-VZ Business. The sale represented about 1.0% of the shares Kyle held before the transaction. The reported ownership figure applies after the sale.
Ownership Position After the Transaction
Kyle’s post-transaction holding was 106,566 shares. The transaction was priced at $49.98 per share.
FAQs
Q: How many Verizon shares did Malady Kyle sell?
A: Malady Kyle sold 1,100 shares of Verizon Communications in the transaction. The shares were sold at $49.98 each on 8 September 2026.
Q: What was the impact of the Verizon insider transaction?
A: Kyle owned 106,566 shares after the transaction. The sale represented about 1.0% of his prior share holding, according to the reported ownership figures.
Q: What does code S mean in a Verizon insider sale?
A: Code S identifies an open-market sale in the transaction classification. The reported sale involved Malady Kyle, Verizon Communications’ EVP and Group CEO-VZ Business.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.